Akira Morimiya

1.4k citations
16 papers · 1.1k indexed · 1 hit paper · h-index 11
Topics
Estrogen and related hormone effects (6 papers)Cancer Cells and Metastasis (4 papers)Inflammatory mediators and NSAID effects (4 papers)

In The Last Decade

Akira Morimiya

16 papers receiving 1.1k citations

Hit Papers

NF-κB represses E-cadherin expression and enhances epithe...20062026201220192006100200300400500

Peers

Akira Morimiya
Comparison fields: 5 of 85
  • Molecular Biology 628
  • Oncology 504
  • Cancer Research 343
  • Genetics 190
  • Pulmonary and Respiratory Medicine 159
Replace Cheng‐Chi Chang with:
Cheng‐Chi Chang Taiwan
Earl Lawrence United States
Georgia Sotiropoulou‐Bonikou Greece
Sandra E. Ghayad France
Wen Bu United States
Ines Koch Germany
Scott Wise United States
Mei‐Ren Pan Taiwan
Jianghua Shao China
Xuesong Ouyang United States
Akira Morimiya relative to Cheng‐Chi Chang Taiwan Cheng‐Chi Chang's profile →
Citations per field
00.5×1.7×
Cheng‐Chi Chang · 1×
Citations per year

Countries citing papers authored by Akira Morimiya

Since Specialization
Citations

This map shows the geographic impact of Akira Morimiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Morimiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Morimiya more than expected).

Fields of papers citing papers by Akira Morimiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Morimiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Morimiya. The network helps show where Akira Morimiya may publish in the future.

Co-authorship network of co-authors of Akira Morimiya

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Morimiya. A scholar is included among the top collaborators of Akira Morimiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Morimiya. Akira Morimiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 6
2 10
3 1
4 9
5 7
6 25
7 97
8 11
9 196
10
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2breakdown →
507
11 35
12 1
13 70
14 71
15 32
16 42

About Akira Morimiya

Akira Morimiya is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Cancer Cells and Metastasis (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Cancer Research (343 citations), Oncology (504 citations) and Molecular Biology (628 citations). Akira Morimiya has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include Sunil Badve, Harikrishna Nakshatri, Poornima Bhat‐Nakshatri, Susan E. Clare, Hui Lin Chua, Mangesh A. Thorat, Sanjana Mehrotra, Beamon Agarwal, Raymond L. Konger and Dmitry Turbin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026